Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2)

[Edit]

MRG1; P35srj; MSG-related protein 1

Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2)
CITED2 inhibits transactivation of HIF1A-induced genes by competing with binding of HIF1a to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Three transcript variants encoding the same protein have been found for this gene. The predicted 213-amino acid human MRG1 protein contains 3 histidine clusters and shares 2 conserved domains with MSG1: the 14-amino acid CR1 (conserved region 1) and the acidic 49-amino acid CR2. The CR2 domain includes 12 aspartic acid and glutamic acid residues that are strictly conserved among the human and mouse MRG1 and MSG1 proteins. Northern blot analysis detected MRG1 expression in normal human epidermal melanocytes and in melanoma cells; mouse Mrg1 transcripts were found in all adult mouse tissues examined except muscle.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cbp/p300 Interacting Transactivator, With Glu/Asp Rich Carboxy Terminal Domain 2 (CITED2) ELISA Kit Customized Service Offer
  1. "msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation."Proc. Natl. Acad. Sci. U.S.A. 93:12298-12303(1996) [PubMed] [Europe PMC] [Abstract]
  2. "Molecular cloning and chromosomal localization of the human CITED2 gene encoding p35srj/Mrg1."Genomics 61:307-313(1999) [PubMed] [Europe PMC] [Abstract]
  3. "Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1."Genes Dev. 13:64-75(1999) [PubMed] [Europe PMC] [Abstract]
  4. "The DNA sequence and analysis of human chromosome 6." Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
  5. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein."Genes Dev. 15:2598-2612(2001) [PubMed] [Europe PMC] [Abstract]
  7. "Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator."Nat. Genet. 29:469-474(2001) [PubMed] [Europe PMC] [Abstract]
  8. "Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2."J. Biol. Chem. 278:16021-16029(2003) [PubMed] [Europe PMC] [Abstract]
  9. "Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator."J. Biol. Chem. 279:24053-24063(2004) [PubMed] [Europe PMC] [Abstract]
  10. "Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2."Nat. Struct. Biol. 10:504-512(2003) [PubMed] [Europe PMC] [Abstract]
  11. "Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites."J. Biol. Chem. 279:3042-3049(2004) [PubMed] [Europe PMC] [Abstract]
  12. "Identification and functional analysis of CITED2 mutations in patients with congenital heart defects."Hum. Mutat. 26:575-582(2005) [PubMed] [Europe PMC] [Abstract]